Chairs
- Emily Breidbart
- Sowmya Krishnan
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
New Meds and Tech: Newer Insulin Preparation – Faster Insulin Aspart (Fiasp)
March 3, 2020
Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier…
New Meds and Tech: Increlex
February 27, 2020
In response to findings of a safety signal report that…